What is the Average Weight Loss on Wegovy Per Month?

Last reviewed: July 8, 2026

Last updated: July 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide has emerged as one of the most effective weight loss medications available, with clinical trials showing an average loss of 15% body weight over 68 weeks. Monthly weight loss varies significantly between individuals because genetics, lifestyle, and baseline metabolism all influence how your body responds to GLP-1 therapy. Understanding realistic expectations helps you stay committed and track meaningful progress.

Typical Monthly Weight Loss Results on Semaglutide

Most patients on semaglutide lose between 1 to 2 pounds per week during early treatment phases, which translates to roughly 4 to 8 pounds in the first 30 days. This initial loss often reflects both water weight and fat loss as your body adjusts to reduced appetite and improved glucose regulation. By month two and three, the rate typically stabilizes to a steady 1 to 1.5 pounds weekly as your metabolism adapts.

Clinical data shows that patients in maintenance phases often achieve 10 to 15 pounds of weight loss monthly once doses reach therapeutic levels. However, these numbers represent averages—your personal results depend on your starting weight, adherence to diet and physical activity, and how your individual peptide pathways respond to the medication. Individuals with higher baseline weights often experience faster initial losses than those with lower starting points.

How Genetics Influence Your Personal Weight Loss Timeline

Your genetic makeup directly affects how efficiently your body processes GLP-1 signals and manages appetite regulation. Key genetic variants like GIPR rs1800437 influence receptor sensitivity, meaning two people on identical doses may experience very different weight loss trajectories. PlexusDx's Precision Peptide Genetic Test maps 14 metabolic pathways and 49 peptides to reveal which genetic predispositions might accelerate or slow your response.

Understanding your FTO rs9939609 and MC4R rs17782313 variants helps explain why some people feel fuller faster on lower doses while others need gradual titration to reach optimal results. This genetic insight allows PlexusDx to personalize your starting dose, escalation schedule, and medication choice—whether compounded semaglutide injection, oral formulation, or a combination therapy—to align with your biology rather than guessing.

Factors Beyond Medication That Affect Monthly Weight Loss

Semaglutide amplifies weight loss but doesn't work in isolation; diet quality, meal timing, and protein intake meaningfully influence how many pounds you'll lose each month. Patients who prioritize whole foods, adequate hydration, and consistent sleep patterns often see 20 to 30% faster fat loss compared to those who rely on medication alone. Conversely, consuming high-calorie foods despite reduced appetite can plateau your progress.

Exercise frequency and intensity also shape monthly outcomes—adding 150 minutes of moderate activity weekly can boost your loss by 0.5 to 1 pound per month beyond semaglutide's baseline effect. Stress levels, sleep quality (7–9 hours nightly), and hormonal cycles in women all influence weight loss variability month to month. PlexusDx considers these lifestyle factors alongside your genetic profile to set realistic monthly targets.

Why Your Monthly Weight Loss May Vary After the First Month

Initial rapid weight loss often gives way to slower, steadier loss after month two because your body adapts to lower calorie intake and medication levels stabilize. This is normal and expected—rapid early loss frequently includes water weight and glycogen depletion, while sustained loss reflects actual fat reduction. Many patients experience mini-plateaus lasting 1–3 weeks, during which the scale doesn't move despite adherence, before dropping again.

Dose escalation timing significantly impacts monthly outcomes; if your provider increases your dose mid-month, you may see a temporary slowdown as your body recalibrates before accelerating again. PlexusDx's compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan) with flexible dosing protocols, allowing seamless adjustments without price increases—your dose may need to go up, but your monthly cost stays the same. This pricing structure supports consistent, uninterrupted therapy to maintain steady monthly progress.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Can I expect to lose the same amount of weight every month?

No—weight loss typically accelerates through months one to three, then stabilizes at a steady 3–6 pounds monthly during maintenance phases. Individual variation is normal and influenced by genetics, adherence, and lifestyle factors. PlexusDx personalizes expectations based on your genetic profile and starting point.

What does clinical trial data say about semaglutide weight loss?

The STEP trials showed semaglutide users achieved approximately 15% average body weight loss (roughly 50 pounds for a 350-pound person) over 68 weeks, with monthly loss varying from 1–2 pounds in early weeks to 3–5 pounds during steady-state treatment. Real-world results often align closely with these benchmarks when combined with lifestyle modification.

Does PlexusDx compounded semaglutide produce the same weight loss as brand-name Wegovy?

Yes—PlexusDx semaglutide comes from licensed 503A compounding pharmacies and uses identical active pharmaceutical ingredients as brand-name products, delivering equivalent weight loss outcomes at a lower cost starting at just $149/mo. No insurance is required, and your price remains flat regardless of dose increases.

What if my monthly weight loss slows or stops?

Weight loss plateaus are common and often resolve with minor adjustments to diet, exercise, or medication dose. PlexusDx providers can review your Precision Peptide Genetic Test results to identify whether your plateau reflects genetic predisposition, lifestyle factors, or dose optimization needs—then adjust your personalized protocol accordingly.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Wegovy For Weight Loss 2
• Average Weight Loss On Ozempic
• Wegovy Weight Loss Pills
• Wegovy Price Per Month

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.